Cited by 46Cardiac Fibrosis and RemodelingAtherosclerosis and Cardiovascular DiseasesImmune cells in cancer

New Approaches to Target Inflammation in Heart Failure: Harnessing Insights from Studies of Immune Cell Diversity

Open access
Rhee, Aaron J., Lavine, Kory J.·2020·Annual Review of Physiology

Abstract

Despite mounting evidence implicating inflammation in cardiovascular diseases, attempts at clinical translation have shown mixed results. Recent preclinical studies have reenergized this field and provided new insights into how to favorably modulate cardiac macrophage function in the context of acute myocardial injury and chronic disease. In this review, we discuss the origins and roles of cardiac macrophage populations in the steady-state and diseased heart, focusing on the human heart and mouse models of ischemia, hypertensive heart disease, and aortic stenosis. Specific attention is given to delineating the roles of tissue-resident and recruited monocyte-derived macrophage subsets. We also highlight emerging concepts of monocyte plasticity and heterogeneity among monocyte-derived macrophages, describe possible mechanisms by which infiltrating monocytes acquire unique macrophage fates, and discuss the putative impact of these populations on cardiac remodeling. Finally, we discuss strategies to target inflammatory macrophage populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-physiol-021119-034412

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anti-inflammatory therapies targeting essential immune modulators are associated with serious adverse events such as a higher incidence of fatal infection and sepsis.

    “they are also associated with serious adverse events such as a higher incidence of fatal infection and sepsis36,38.”

    From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [38]

    In “Targeting Monocytes and Macrophages in Heart Failure” (page unavailable), the review says immune-suppressing or immune-modulating therapies may increase the risk of opportunistic or life-threatening infections, citing CANTOS as an example. Our copy does not specify a higher incidence of fatal infection or sepsis, so those details are not supported. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [102]Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, 2018 The human heart contains distinct macrophage subsets with divergent origins and functions. Nat. Med 24: 1234– 45 29892064 PMC6082687

Cited by

Sorted by citations

Authors
Rhee, A. J., & Lavine, K. J.
Affiliations
Washington University in St. Louis (US)
Venue
Annual Review of Physiology
Published
2020-02-10
Volume
82
Issue
1
Pages
1-20
ISSN
  • 0066-4278 (ISSN-L)
  • 1545-1585
OpenAlex
W2982287350
Cited by
46
References
114
Citations by year
2026: 5 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 7 · 2020: 4
FWCI
0.86
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL138466, R01HL139714, K08HL123519)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
heart failure, inflammation, cardiac macrophages, monocyte-derived macrophages, monocyte plasticity, monocyte heterogeneity, acute myocardial injury, ischemia, hypertensive heart disease, aortic stenosis, cardiac remodeling, tissue-resident macrophages, macrophage-targeted therapy
MeSH terms
Animals, Heart Failure, Humans, Immunity, Cellular, Inflammation, Macrophages, Monocytes, Myocardium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review